Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Receivables (2023 - 2025)

Historic Receivables for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $13046.0.

  • Onconetix's Receivables fell 9717.02% to $13046.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $13046.0, marking a year-over-year decrease of 9717.02%. This contributed to the annual value of $26000.0 for FY2024, which is 9158.58% down from last year.
  • Onconetix's Receivables amounted to $13046.0 in Q3 2025, which was down 9717.02% from $24599.0 recorded in Q2 2025.
  • In the past 5 years, Onconetix's Receivables registered a high of $1.0 million during Q3 2023, and its lowest value of $13046.0 during Q3 2025.
  • For the 3-year period, Onconetix's Receivables averaged around $324577.5, with its median value being $309000.0 (2023).
  • Per our database at Business Quant, Onconetix's Receivables surged by 45571.43% in 2024 and then tumbled by 9717.02% in 2025.
  • Over the past 3 years, Onconetix's Receivables (Quarter) stood at $309000.0 in 2023, then decreased by 10.58% to $276308.0 in 2024, then crashed by 95.28% to $13046.0 in 2025.
  • Its last three reported values are $13046.0 in Q3 2025, $24599.0 for Q2 2025, and $27057.0 during Q1 2025.